Evidence map›Paper›PMID 31076455›Full record

ArticleThe Journal of experimental medicine2019

Hlf marks the developmental pathway for hematopoietic stem cells but not for erythro-myeloid progenitors.

Tomomasa Yokomizo, Naoki Watanabe, Terumasa Umemoto, Junichi Matsuo, Ryota Harai, Yoshihiko Kihara, Eri Nakamura, Norihiro Tada, Tomohiko Sato, Tomoiku Takaku and 9 more

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Linker histone regulates the myeloid versus lymphoid bifurcation of multipotent hematopoietic stem and progenitors.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Tomomasa YokomizoInternational Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan tomoyokomizo@gmail.com.ORCID 0000-0001-6157-2852
Naoki WatanabeDepartment of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0001-6377-0174
Terumasa UmemotoInternational Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan.ORCID 0000-0003-0423-9003
Junichi MatsuoCancer Science Institute of Singapore, National University of Singapore, Singapore.
Ryota HaraiInternational Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan.
Yoshihiko KiharaDepartment of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0002-7202-3741
Eri NakamuraLaboratory of Genome Research, Research Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Norihiro TadaLaboratory of Genome Research, Research Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Tomohiko SatoDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Tomoiku TakakuDepartment of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Akihiko ShimonoCancer Science Institute of Singapore, National University of Singapore, Singapore.
Hitoshi TakizawaInternational Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan.
Naomi NakagataDivision of Reproductive Engineering, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan.
Seiichi MoriDivision of Cancer Genomics, Cancer Institute of Japanese Foundation for Cancer Research, Tokyo, Japan.
Mineo KurokawaDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Daniel G TenenCancer Science Institute of Singapore, National University of Singapore, Singapore.ORCID 0000-0002-6423-3888
Motomi OsatoInternational Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan.ORCID 0000-0003-3982-9054
Toshio SudaInternational Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan csits@nus.edu.sg.ORCID 0000-0001-7540-1771
Norio KomatsuDepartment of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Funding

Transcriptional and epigenetic heterogeneity of stem/progenitor cellsP01HL131477 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI DANIEL G TENEN · 2017 to 2026
$24.6M
Mechanisms of regulation by RNA in acute myeloid leukemiaR35CA197697 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TENEN, DANIEL G · 2015 to 2021
$7.1M
NCI NIH HHS R35 CA197697NHLBI NIH HHS P01 HL131477
6 · The paper itself

Abstract

Before the emergence of hematopoietic stem cells (HSCs), lineage-restricted progenitors, such as erythro-myeloid progenitors (EMPs), are detected in the embryo or in pluripotent stem cell cultures in vitro. Although both HSCs and EMPs are derived from hemogenic endothelium, it remains unclear how and when these two developmental programs are segregated during ontogeny. Here, we show that hepatic leukemia factor (Hlf) expression specifically marks a developmental continuum between HSC precursors and HSCs. Using the

Indexed as

HematopoiesisAnimalsBasic-Leucine Zipper Transcription FactorsCell LineageErythroid Precursor CellsFemaleHematopoietic Stem CellsLiverMaleMice, Inbred C57BLMyeloid Progenitor CellsPluripotent Stem CellsYolk SacBasic-Leucine Zipper Transcription FactorsHlf protein, mouse

Identifiers

PMID31076455
PMCPMC6605751

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.